Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Dinh, T.-H.*; Suzuki, Yuhei*; Arai, Goki*; Li, B.*; Dunne, P.*; O'Sullivan, G.*; Fujioka, Shinsuke*; Hasegawa, Noboru; Kawachi, Tetsuya; Nishikino, Masaharu; et al.
Applied Physics Letters, 107(12), p.121101_1 - 121101_5, 2015/09
Times Cited Count：5 Percentile：21.76(Physics, Applied)
-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancerSuzuki, Shigemasa*; Kaira, Kyoichi*; Ohshima, Yasuhiro; Ishioka, Noriko; Soda, Makoto*; Yokobori, Takehiko*; Miyazaki, Tatsuya*; Oriuchi, Noboru*; Tominaga, Hideyuki*; Kanai, Yoshikatsu*; et al.
British Journal of Cancer, 110(8), p.1985 - 1991, 2014/04
Times Cited Count：25 Percentile：59.80(Oncology)Iida, Yasuhiko*; Hanaoka, Hirofumi*; Watanabe, Satoshi; Watanabe, Shigeki; Ishioka, Noriko; Yoshioka, Hiroki*; Yamamoto, Shinji*; Paudyal, P.*; Paudyal, B.*; Higuchi, Tetsuya*; et al.
JAEA-Review 2009-041, JAEA Takasaki Annual Report 2008, P. 108, 2009/12
Cu-labeled DOTA-
-Phe
-Tyr
-octreotide (Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumorsHanaoka, Hirofumi*; Tominaga, Hideyuki*; Yamada, Keiichi*; Paudyal, P.*; Iida, Yasuhiko*; Watanabe, Shigeki; Paudyal, B.*; Higuchi, Tetsuya*; Oriuchi, Noboru*; Endo, Keigo*
Annals of Nuclear Medicine, 23(6), p.559 - 567, 2009/08
Times Cited Count：18 Percentile：49.43(Radiology, Nuclear Medicine & Medical Imaging)Iida, Yasuhiko*; Hanaoka, Hirofumi*; Paudyal, P.*; Paudyal, B.*; Watanabe, Satoshi; Ishioka, Noriko; Watanabe, Shigeki; Matsuhashi, Shimpei; Yoshioka, Hiroki*; Higuchi, Tetsuya*; et al.
JAEA-Review 2008-055, JAEA Takasaki Annual Report 2007, P. 114, 2008/11
Iida, Yasuhiko*; Hanaoka, Hirofumi*; Katabuchi, Tatsuya*; Watanabe, Shigeki; Ishioka, Noriko; Watanabe, Satoshi; Matsuhashi, Shimpei; Higuchi, Tetsuya*; Oriuchi, Noboru*; Endo, Keigo*
JAEA-Review 2007-060, JAEA Takasaki Annual Report 2006, P. 128, 2008/03
Shimada, Kenya*; Higashiguchi, Mitsuharu*; Arita, Masashi*; Namatame, Hirofumi*; Taniguchi, Masaki*; Fujimori, Shinichi; Saito, Yuji; Fujimori, Atsushi; Takata, Yasutaka*; Shin, S.*; et al.
Journal of Magnetism and Magnetic Materials, 310(2, Part1), p.e57 - e58, 2007/03
We have examined the electronic states of the Kondo semiconductor CeRhAs and the semimetal CeRhSb by means of high-resolution photoemission spectroscopy using tunable photon energies from 40 up to 5948 eV. On the basis of the photon-energy dependence ofthe photoionization cross-section, we have elucidated the p-d-f hybridized states in these compounds.
Iida, Yasuhiko*; Hanaoka, Hirofumi*; Katabuchi, Tatsuya*; Watanabe, Satoshi; Ishioka, Noriko; Matsuhashi, Shimpei; Oriuchi, Noboru*; Higuchi, Tetsuya*; Miyakubo, Mitsuyuki*; Endo, Keigo*
JAEA-Review 2006-042, JAEA Takasaki Annual Report 2005, P. 165, 2007/02
La
RhAs; A Collapse of the energy gap in the Kondo semiconductorShimada, Kenya*; Higashiguchi, Mitsuharu*; Fujimori, Shinichi; Saito, Yuji; Fujimori, Atsushi; Namatame, Hirofumi*; Taniguchi, Masaki*; Sasakawa, Tetsuya*; Takabatake, Toshiro*
Physica B; Condensed Matter, 383(1), p.140 - 141, 2006/08
Times Cited Count：1 Percentile：6.21(Physics, Condensed Matter)High-resolution resonance-photoemission spectroscopy has been performed on the CeLaRhAs (0
x0.05) single crystal to elucidate a collapse of the energy gap in the Kondo semiconductor CeRhAs by La substitution. With increasing x, the spectral intensity of the Ce 4f derived states near the Fermi level decreases and new 4f derived spectral feature appears at a higher binding energy. The Rh 4d-derived states, on the other hand, are not significantly changed by the substitution. New 4f-derived states have incoherent nature, which is responsible for the collapse of the semiconducting state for x
0.02.
(T=Rh, Ir, and Co); Band-calculation and tight-binding approachMaehira, Takahiro; Takimoto, Tetsuya; Hotta, Takashi; Ueda, Kazuo*; Higuchi, Masahiko*; Hasegawa, Akira*
Journal of the Physical Society of Japan, Vol.71, Supplement, p.285 - 287, 2002/00
Times Cited Count：8 Percentile：49.64(Physics, Multidisciplinary)Recently a new family of Ce-based heavy fermion superconductor 
(T=Rh, Ir, and Co) has been reported. The dHvA effect has been successfully observed in 
and 
.The angular dependence of dHvA branches is well explained by a quasi-two dimensional Fermi surface(F.S.). In order to clarify band structures of Ce-115 systems such as CeIrIn and CeCoGa, two-step strategy is here employed. In the first step, the F.S. are derived by using the RLAPW method. In the next step, the band structure near the Fermi level is reanalyzed by using a simple tight-binding model. Namely, hopping amplitudes of 
-electrons between neighboring Ce ions are parameterized to reproduce the F.S. obtained in the band-calculation. By further adding the Coulomb interaction terms into this tight-binding model, a simple many-body Hamiltonian for Ce-compounds can be constructed. This Hamiltonian opens a way to discuss magnetism and superconductivity in -electron systems from the microscopic viewpoint.
Iida, Yasuhiko*; Hanaoka, Hirofumi*; Watanabe, Satoshi; Ishioka, Noriko; Watanabe, Shigeki; Matsuhashi, Shimpei; Paudyal, B.*; Oriuchi, Noboru*; Higuchi, Tetsuya*; Endo, Keigo*
no journal, ,
Lu -labeled antibody for cancer therapyHanaoka, Hirofumi*; Iida, Yasuhiko*; Higuchi, Tetsuya*; Oriuchi, Noboru*; Endo, Keigo*; Watanabe, Satoshi; Watanabe, Shigeki; Ishioka, Noriko
no journal, ,
no abstracts in English
Iida, Yasuhiko*; Hanaoka, Hirofumi*; Yoshioka, Hiroki*; Miyakubo, Mitsuyuki*; Paudyal, B.*; Higuchi, Tetsuya*; Oriuchi, Noboru*; Endo, Keigo*; Katabuchi, Tatsuya*; Ishioka, Noriko; et al.
no journal, ,
no abstracts in English
Iida, Yasuhiko*; Paudyal, P.*; Yoshioka, Hiroki*; Tominaga, Hideyuki*; Hanaoka, Hirofumi*; Zhang, S.*; Hosaka, Masahiro*; Takeuchi, Toshiyuki*; Tobita, Seiji*; Watanabe, Satoshi; et al.
no journal, ,
no abstracts in English
Cu labeled monoclonal antibodyPaudyal, P.*; Paudyal, B.*; Iida, Yasuhiko*; Hanaoka, Hirofumi*; Watanabe, Satoshi; Ishioka, Noriko; Watanabe, Shigeki; Takayanagi, Megumi*; Yoshioka, Hiroki*; Oriuchi, Noboru*; et al.
no journal, ,
Ishioka, Noriko; Hanaoka, Hirofumi*; Iida, Yasuhiko*; Watanabe, Satoshi; Watanabe, Shigeki; Oriuchi, Noboru*; Higuchi, Tetsuya*; Hashimoto, Kazuyuki; Endo, Keigo*
no journal, ,
no abstracts in English
Br-labeled amino acid derivative for PET imaging of tumorHanaoka, Hirofumi*; Watanabe, Shigeki; Tominaga, Hideyuki*; Ohshima, Yasuhiro; Tsukui, Narutaka; Watanabe, Satoshi; Yamada, Keiichi*; Iida, Yasuhiko*; Oriuchi, Noboru*; Higuchi, Tetsuya*; et al.
no journal, ,
no abstracts in English
Lu-labeled antibody for cancer therapyHanaoka, Hirofumi*; Hashimoto, Kazuyuki; Watanabe, Satoshi; Ishioka, Noriko; Watanabe, Shigeki; Oriuchi, Noboru*; Higuchi, Tetsuya*; Iida, Yasuhiko*; Endo, Keigo*
no journal, ,
no abstracts in English
Hanaoka, Hirofumi*; Hashimoto, Kazuyuki; Watanabe, Satoshi; Ishioka, Noriko; Ohshima, Yasuhiro; Watanabe, Shigeki; Oriuchi, Noboru*; Higuchi, Tetsuya*; Iida, Yasuhiko*; Endo, Keigo*
no journal, ,
no abstracts in English
Br- or Cu-labeled antibody for immuno-PET in quantitative evaluation of radioimmunotherapyIida, Yasuhiko*; Hanaoka, Hirofumi*; Ishioka, Noriko; Katabuchi, Tatsuya*; Watanabe, Satoshi; Watanabe, Shigeki; Matsuhashi, Shimpei; Higuchi, Tetsuya*; Oriuchi, Noboru*; Endo, Keigo*
no journal, ,
